Report Highlights
The global market for fluoroscopy and C-arms reached $2.2 billion in 2017 and should reach nearly $2.7 billion in 2022 at a compound annual growth rate (CAGR) of 3.8% for the period of 2017-2022.
Report Includes
- 51 data tables
- An overview of the global fluoroscopy and C-arms market and related technologies
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- An outline of the present state of applications of fluoroscopy and C-arms
- Descriptions of trends in price and price-performance and other factors, including demand in the market
- Profiles of key companies in the market, including Canon Inc., DMS Imaging., GE Healthcare, Hitachi Ltd, and Omega Medical Imaging LLC.
Report Scope
This report focuses on the global market for fluoroscopy products and provides an updated review including its types and its applications in various clinical fields. Clinical fields considered in this report are vascular, orthopedics, gastrointestinal, endoscopic, urologic, neurologic, critical care, pain management, and emergency procedures. The fluoroscopy and mobile C-arms market is mainly driven by growing cases of age-related alignments, chronic conditions and non-communicable diseases, and the corresponding increase in the number of surgeries. The scope of the study is global. BCC analyzes each market and its application, regulatory environment, new products and advancements, market projections and market shares. It is important to note that this report only includes full-sized C-arm systems for the purpose of analysis. Mini C-arm systems have not been included in the analysis of this study.
Also included in the report are relevant patent analysis and comprehensive profiles of companies that lead the fluoroscopy industry. Few major players that dominate the market for fluoroscopic devices are GE Healthcare (part of General Electric Co.), Philips Healthcare (part of Koninklijke Philips N.V.) and Siemens Healthcare GmbH (part of Siemens AG). Other significant players in the global fluoroscopic device are Canon Inc., Carestream Health Inc. (part of the Onex Corp.), Gemss Medical Systems Co. Ltd., Genoray Co. Ltd., Hologic Inc., Omega Medical Imaging LLC, OrthoScan Inc., Shimadzu Corp., Toshiba Medical Systems Corp. (part of Canon Inc.), Villa Sistemi Medicali SPA, Ziehm Imaging Inc. etc. The report includes company details and product profiles along with a competitive analysis of market participants.
The regional distribution of the market includes North America (the U.S. and Canada), Europe (Germany, the United Kingdom, France, Spain, Italy, Scandinavia, and Benelux) and emerging markets. The report provides market estimates and projections in terms of unit shipments and revenues for the forecast period 2017-2022. The market data pertains to new product/unit sales and does not include replacement or refurbished systems.
Analyst Credentials
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
Report Highlights
The global market for fluoroscopy and mobile C-arms was valued at $1.7 billion in 2013 and is expected to grow at a compound annual growth rate (CAGR) of 3.2% from 2013 to 2018, reaching $2.0 billion in 2018.
Report Includes
- An overview of the global market for fluoroscopy and mobile C-arms.
- Analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
- Information on market trends, emerging applications, breakdowns of market shares, and details concerning end user trends.
- A geographical breakdown of the market into the following major regions: the U.S., Canada, Europe, Asia-Pacific, and the rest of the world.
Related Reports
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Medical Robotics and Computer-assisted Surgery: The Global Market
The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
The Market for Minimally Invasive Medical Devices
The global minimally invasive medical devices market should reach $41.0 billion by 2028 from $28.5 billion in 2023 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2023 to 2028.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More